| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 07/09/2003 | EP1325932A2 Anti-vegf antibodies |
| 07/09/2003 | EP1325338A2 Diagnosis and treatment of alzheimer's disease |
| 07/09/2003 | EP1325133A2 Bvh-a2 and bvh-a3 antigens of group b streptococcus |
| 07/09/2003 | EP1325130A2 Nogo receptor homologs |
| 07/09/2003 | EP1325128A2 Lipocalins |
| 07/09/2003 | EP1325031A2 Use of anti-human integrin alpha d antibodies to treat spinal cord injury |
| 07/09/2003 | EP1325030A2 Genes isolated from dendritic cells, gene products and methods employing the same |
| 07/09/2003 | EP1325029A2 Secreted proteins and their uses |
| 07/09/2003 | EP1325028A2 New inhibitors of iapp fibril formation and uses thereof |
| 07/09/2003 | EP1324776A2 Reduced-viscosity concentrated protein formulations |
| 07/09/2003 | EP1324772A2 Methods for treating disorders of the female reproductive system |
| 07/09/2003 | EP1324771A2 Therapeutic antibodies |
| 07/09/2003 | EP1324769A2 Split enveloped virus preparation for intranasal delivery |
| 07/09/2003 | EP1324768A2 Vaccines for proliferative ileitis |
| 07/09/2003 | EP1080109B1 Method for purification of borrelia lipoprotein ospa |
| 07/09/2003 | EP1071752B1 CD19xCD3 SPECIFIC POLYPEPTIDES AND USES THEREOF |
| 07/09/2003 | EP0920443B1 Activated peptides and conjugates |
| 07/09/2003 | EP0900380B1 Methods for selecting and producing t cell peptide epitopes and vaccines incorporating said selected epitopes |
| 07/09/2003 | EP0741787B1 Mammalian expression systems for hepatitis c virus envelope genes |
| 07/09/2003 | EP0716613B1 Treatment of helicobacter associated gastroduodenal disease |
| 07/09/2003 | EP0686260B1 Human carcinoma antigen (hca), hca antibodies, hca immunoassays, methods of imaging and therapy |
| 07/09/2003 | EP0619738B1 Inhibitory immunoglobulin polypeptides to human pdgf beta receptor |
| 07/09/2003 | EP0511308B2 Chimeric immunoglobulin for cd4 receptors |
| 07/09/2003 | CN1429276A Modulating production of pneumococcal capsular polysaccharide |
| 07/09/2003 | CN1429235A Full-length infectious CDNA clones of tick borne flavivirus |
| 07/09/2003 | CN1429118A Aromatase inhibitors and monoclonal anti-HER2 anti-bodies as antitumors agents |
| 07/09/2003 | CN1428428A Biological reactor using peanut cotyledon as object protein production platform |
| 07/09/2003 | CN1428427A Endoplasmic target polypeptide expression box |
| 07/09/2003 | CN1428426A Programmed cell death induction molecule II |
| 07/09/2003 | CN1428352A Reformed monoclonal antibody for resisting immunoglobulin homoeotype |
| 07/09/2003 | CN1113599C Antimicrobial treatment method for herpes simplex virus and other infectious diseases |
| 07/08/2003 | US6590079 Vitazin antibody; treating angiogenesis or restenosis |
| 07/08/2003 | US6590076 Isolated polypeptide, of given sequence, comprising at least an immunogenic portion of a tumor antigen; may be used to generate antibodies |
| 07/08/2003 | US6589940 Immunostimulatory oligonucleotides, compositions thereof and methods of use thereof |
| 07/08/2003 | US6589560 Stable glassy state powder formulations |
| 07/08/2003 | US6589533 Able to span or correctly integrate into cell membrane of insects but not mammals |
| 07/08/2003 | US6589532 Papilloma viruses, means for the detection thereof and therapy for diseases caused thereby |
| 07/08/2003 | US6589531 Recombinant yellow fever virus and method of use thereof |
| 07/08/2003 | US6589530 Hepatitis B surface antigen vaccine |
| 07/08/2003 | US6589529 Recombinant fusion proteins as immunogens; VP6 protein or carboxy- terminal fragment |
| 07/08/2003 | US6589528 Contacting monocytes with monoclonal antibody that binds to fusion regulatory Protein-1 exposed on surface of monocytes |
| 07/08/2003 | US6589527 Using binding substance to connect antibodies to target that they normally have no functional specificity for |
| 07/08/2003 | US6589522 Vaccines against infections caused by YF virus; YF infectious cDNA, method for producing a recombinant YF virus from the YF infectious cDNA and plasmids to assemble the YF infectious cDNA |
| 07/08/2003 | CA2301000C An attenuated japanese encephalitis virus adapted to vero cell and a japanese encephalitis vaccine |
| 07/08/2003 | CA2133646C Stem cell proliferation factor |
| 07/08/2003 | CA2068593C Method for reducing the immunogenicity of antibody variable domains |
| 07/03/2003 | WO2003054541A2 Inhibition of tristetraproline for protection of the heart from cardiac injuries |
| 07/03/2003 | WO2003054540A1 Dna encoding a human receptor (hp15a) and uses thereof |
| 07/03/2003 | WO2003054216A2 Antibodies that immunospecifically bind to trail receptors |
| 07/03/2003 | WO2003054212A2 A method and compositions for conferring viral immunity and reversing viral pathogenesis via strategic infection with a theravirus thereby providing genomic integration of genetically engineered, replication incompetent, integrating viral dna |
| 07/03/2003 | WO2003054176A2 Preparation of vaccines using photosensitizer and light |
| 07/03/2003 | WO2003054175A1 Method for the recovery and purification of poxviruses from infected cells |
| 07/03/2003 | WO2003054159A2 Modulating insulin receptor signaling through targeting facl |
| 07/03/2003 | WO2003054157A2 Dna encoding novel cyclic gmp dependent protein kinases from two protozoal sources for use as chemotherapeutic targets for antiprotozoal agents |
| 07/03/2003 | WO2003054150A2 Apoptotic ebv-transformed lymphocytes, a therapeutic agent for post-transplant lymphoproliferative disorder |
| 07/03/2003 | WO2003054141A2 Sperm-specific cation channel, catsper2, and uses therefor |
| 07/03/2003 | WO2003054019A2 Therapeutic monoclonal anti-tirc7 antibodies for use in immune related and other diseases |
| 07/03/2003 | WO2003054018A2 Anti-tirc7 antibodies in therapy of inflammatory diseases |
| 07/03/2003 | WO2003054012A2 Leptin proteins |
| 07/03/2003 | WO2003054008A2 Mammalian simp protein, gene sequence and uses thereof in cancer therapy |
| 07/03/2003 | WO2003054007A2 Streptococcus antigens |
| 07/03/2003 | WO2003054006A2 Mutated hiv tat |
| 07/03/2003 | WO2003054004A2 Secreted proteins |
| 07/03/2003 | WO2003053473A2 Ph-sensitive polymeric conjugates of an anthracycline drug |
| 07/03/2003 | WO2003053465A2 Lyophilized preparation containing antibodies to the egf receptor |
| 07/03/2003 | WO2003053464A1 Immunogenic compositions comprising an antigen and a purified m protein from respiratory syncytial virus |
| 07/03/2003 | WO2003053463A2 Poxvirus-containing compositions and process for their preparation |
| 07/03/2003 | WO2003053462A2 Staphylococcus aureus exopolysaccharide and process |
| 07/03/2003 | WO2003053461A2 Lactic acid bacteria for preventing infection with intimin expressing pathogens |
| 07/03/2003 | WO2003053364A2 Methods and compositions in treating pain and painful disorders using 1465,1587, 2146, 2207, 32838, 336 and 52908 |
| 07/03/2003 | WO2003053338A2 Novel chimeric rev, tat, and nef antigens |
| 07/03/2003 | WO2003053334A2 Compositions and methods for the diagnosis and treatment of tumor |
| 07/03/2003 | WO2003053220A2 Compositions and methods for the therapy and diagnosis of inflammatory bowel disease |
| 07/03/2003 | WO2003053219A2 Methods for slowing senescence and treating and preventing diseases associated with senescence |
| 07/03/2003 | WO2003029488A3 A method for the early detection of cancer |
| 07/03/2003 | WO2003011215A3 Method and system to determine revised dosage |
| 07/03/2003 | WO2002101009A3 Structural and cytoskeleton-associated proteins |
| 07/03/2003 | WO2002098898A3 FLJs AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE |
| 07/03/2003 | WO2002090383A3 M. catarrhalis antigens |
| 07/03/2003 | WO2002084249A3 Therapeutic and diagnostic uses of antibody specificity profiles |
| 07/03/2003 | WO2002076497A3 Method and composition |
| 07/03/2003 | WO2002074802A3 Recombinant p. vivax merozoite protein-1 p42 vaccine |
| 07/03/2003 | WO2002072616A3 Transfection complexes |
| 07/03/2003 | WO2002070657A3 93870, a human g-protein coupled receptor and uses therefor |
| 07/03/2003 | WO2002059604A3 Diagnosis and treatment of multiple sclerosis |
| 07/03/2003 | WO2002050279A3 Nucleic acid-associated proteins |
| 07/03/2003 | WO2002042776A3 Compositions and methods relating to prostate specific genes and proteins |
| 07/03/2003 | WO2002028998A3 Chlamydia pmp proteins, gene sequences and uses thereof |
| 07/03/2003 | WO2002028481A9 Methods of therapy for b-cell malignancies using antagonist anti-cd40 antibodies |
| 07/03/2003 | WO2002024733A3 Human polynucleotides and polypeptides encoded thereby |
| 07/03/2003 | WO2002020049A3 Eiav chimeric vaccine and diagnostic |
| 07/03/2003 | WO2002012447B1 Isolation and use of solid tumor stem cells |
| 07/03/2003 | WO2002006317A3 Compositions and methods for the therapy and diagnosis of ovarian cancer |
| 07/03/2003 | WO2001083750A9 Dendritic cell co-stimulator molecules |
| 07/03/2003 | US20030126626 Rodent model which cultures human liver cells for regeneration of tissues, providing alternative to liver transplantation; side effect reduction; drug screening |
| 07/03/2003 | US20030125537 Neovascularization; platelet derived growth factors; vascular permeability factors; wound healing agents; antitumor/antiproliferative agents; antisense agents; for treatment of intestinal malabsorption syndrome |
| 07/03/2003 | US20030125536 Fusion proteins/antigen presenting cells for promoting expansion of lymphocytes; vaccines |
| 07/03/2003 | US20030125535 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 07/03/2003 | US20030125533 Regulation of human sphingosine kinase-like protein |
| 07/03/2003 | US20030125519 Ligand for the c-kit receptor and methods of use thereof |